EIF5A and glioblastoma: Treatment of glioblastoma cells with GC7 in vitro resulted in a reduced amount of modified eIF-5A (50% in G55T2 and 45% in U87-MG) indicated by a second, more acidic eIF-5A spot in 2D-Western blot (Figure 3A).